Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAN1B1 divergent transcript (MAN1B1-DT) is a long non-coding RNA gene located on chromosome 9 in humans, positioned head-to-head with the protein-coding MAN1B1 gene. The transcript is described in genomic annotation resources (HGNC, Alliance of Genome Resources) as "MAN1B1 divergent transcript," with MAN1B1-AS1 and "MAN1B1 antisense RNA 1 (head to head)" recognized as alternative names[2][4]. Currently, there is no experimentally-confirmed function, disease linkage, or protein product attributed to MAN1B1-DT; this distinguishes it from the unrelated protein-coding gene MAN1B1, which encodes a glycosyl hydrolase enzyme involved in glycoprotein quality control in the ER[1][3]. There is no evidence to support MAN1B1-DT as a therapeutic target, biomarker, or drug interaction molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAN1B1 divergent transcript (MAN1B1-DT).